Concert Medical LLC’s new coronary guidewire, the Conductor line, hit the market in the U.S. about 10 months after winning 510(k) clearance from the Food & Drug Administration.
The Norwell, Mass.-based company said the FDA cleared the guidewire line in September 2009.
Concert Medical said its new guidewires are stronger and “offer enhanced trackability and crossability,” according to a press release. The company’s new lead wiring also has a hydrophilic coating, designed to improve tactile feel, and shaft markers at 90cm and 100cm for easier insertion measurement.
The 28-year-old developer of interventional cardiology products transitioned from contract manufacturing to a private label and “proprietary medical device product development” in 2005, according to the release.